Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

M Begoña Ruiz-Argüello; Ainara Maguregui; Ainhoa Ruiz del Agua; Dora Pascual-Salcedo; Ana Martínez-Feito; Teresa Jurado; Chamaida Plasencia; Alejandro Balsa; Francisca Llinares-Tello; José Rosas; Nerea Torres; Antonio Martínez; Daniel Nagore

doi:10.1136/annrheumdis-2015-208684

Article info

Clinical and epidemiological research

Concise report

Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

Authors

M Begoña Ruiz-Argüello R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles
Ainara Maguregui R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles
Ainhoa Ruiz del Agua R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles
Dora Pascual-Salcedo Immunology Unit, La Paz University Hospital, Madrid, Spain PubMed articles Google scholar articles
Ana Martínez-Feito Immunology Unit, La Paz University Hospital-Idipaz, Madrid, Spain PubMed articles Google scholar articles
Teresa Jurado Rheumatology Department, La Paz University Hospital, Madrid, Spain PubMed articles Google scholar articles
Chamaida Plasencia Rheumatology Department, La Paz University Hospital, Madrid, Spain PubMed articles Google scholar articles
Alejandro Balsa Rheumatology Department, La Paz University Hospital, Madrid, Spain PubMed articles Google scholar articles
Francisca Llinares-Tello Clinical Analysis, Hospital Marina Baixa, Villajoyosa, Spain PubMed articles Google scholar articles
José Rosas Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain PubMed articles Google scholar articles
Nerea Torres R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles
Antonio Martínez R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles
Daniel Nagore R&D Department, Progenika-Grifols, Derio, Spain PubMed articles Google scholar articles

Correspondence to Dr Daniel Nagore, Progenika-Grifols, 504 Parque Tecnológico Bizkaia, Derio 48160 Spain; daniel.nagore{at}progenika.grifols.com

View Full Text

Citation

Ruiz-Argüello MB, Maguregui A, Ruiz del Agua A, et al

Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars

Annals of the Rheumatic Diseases 2016;75:1693-1696.

Publication history

Received September 29, 2015
Revised February 16, 2016
Accepted February 21, 2016
First published March 10, 2016.

Online issue publication

August 10, 2016

Article Versions

Previous version (10 March 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password